Immediate Impact
3 from Science/Nature 58 standout
Citing Papers
From periphery to center stage: 50 years of advancements in innate immunity
2024 Standout
Multiple myeloma
2024 Standout
Works of Naoki Takezako being referenced
Elotuzumab Plus Pomalidomide and Dexamethasone for Relapsed/Refractory Multiple Myeloma: Final Overall Survival Analysis From the Randomized Phase II ELOQUENT-3 Trial
2022
Prognostic Value of Sequencing-Based Minimal Residual Disease Detection in Multiple Myeloma
2014
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Naoki Takezako | 1149 | 829 | 715 | 100 | 1.8k | |
| Selim Corbacioglu | 1291 | 608 | 510 | 102 | 2.6k | |
| Carlos Fernández de Larrea | 1086 | 844 | 1133 | 130 | 2.1k | |
| Anne Huynh | 1575 | 580 | 608 | 127 | 2.6k | |
| Olivier Decaux | 1049 | 543 | 851 | 78 | 1.8k | |
| Chan‐Jeoung Park | 1184 | 563 | 553 | 183 | 2.3k | |
| Sunil Abhyankar | 1191 | 466 | 441 | 139 | 1.9k | |
| Kyoo‐Hyung Lee | 1612 | 724 | 524 | 167 | 2.5k | |
| Julián Sevilla | 1129 | 468 | 516 | 136 | 2.3k | |
| Angela Michelutti | 686 | 650 | 554 | 62 | 1.8k | |
| Janet Cuttner | 1380 | 688 | 603 | 86 | 2.6k |
All Works
Login with ORCID to disown or claim papers
Loading papers...